UGT1A1 and Hyperbilirubinemia: Concerning the only case of grade 2 hyperbilirubinemia (>1.5–3.0 × ULN), it corresponds to a patient UGT1A1*28/*28 homozygous receiving ATV (and RAL) in combination.